Skip to main content
. 2023 Nov 13;3:1274776. doi: 10.3389/fepid.2023.1274776

Table 1.

Baseline characteristics of study participants.

Characteristic District hospital
Ntchisi Mchinji Balaka Machinga Total
(n = 5,072) (n = 4,225) (n = 2,623) (n = 3,543) (N = 15,463)
Hospitalization outcome, n (%)
Discharged alive 4,802 (96.2) 3,955 (94.0) 2,478 (94.9) 3,363 (95.1) 14,598 (95.1)
Dead 75 (1.5) 100 (2.4) 75 (2.9) 90 (2.5) 340 (2.2)
Referred to other hospitals 13 (0.3) 33 (0.8) 10 (0.4) 22 (0.6) 78 (0.5)
Absconded 102 (2.0) 118 (1.8) 47 (1.8) 62 (1.8) 329 (2.1)
Age of child, n (%)
 1–11 months 1,233 (24.3) 922 (21.8) 576 (22.0) 795 (22.5) 3,526 (22.8)
 12–35 months 2,902 (57.3) 2,470 (58.5) 1,481 (56.6) 2,002 (56.6) 8,855 (57.3)
 36–59 months 932 (18.4) 830 (19.7) 562 (21.5) 741 (20.9) 741 (20.9)
Gender, Male, n (%) 2,889 2,268 1,463 1,987 8,607
(57.0) (53.7) (55.8) (56.1) (55.7)
Fever on admission, > 37.5 °C, n (%) 2,534/4,569 (55.5) 1,495/3,543 (42.2) 448/729 (61.5) 1,337/2,303 (58.1) 5,814/11,144 (52.2)
History of fever in last 7 days, n (%) 4,367 3,429 2,181 2,947 12,924
(86.1) (81.2) (83.2) (83.2) (83.6)
HIV status, n (%)
 Negative 912 2,683 2,067 1,992 7,654
(18.2) (63.6) (79.2) (56.3) (49.9)
 Positive 5 (0.1) 27 (0.6) 22 (0.8) 35 (1.0) 89 (0.6)
 Exposed but uninfectedb 6 (0.1) 42 (1.0) 75 (2.9) 24 (0.7) 147 (1.0)
 Unknown 4,079 1,454 446 1,486 7,465
(81.6) (34.6) (17.1) (42.0) (48.6)
Malaria positive by mRDT, n (%) 2,103/4,005 2,010/2,998 974/1,468 1,866/3,063 6,953/11,534
(52.5) (67.0) (66.4) (60.9) (60.3)
Malnourished, MUACa <11.5 cm, n (%) 300 (5.9) 209 (4.9) 128 (4.9) 299 (8.4) 936 (6.1)
Severe anemia (HB < 5 g/dl), n (%) 211/2,051 (10.3) 285/2,046 (13.9) 142/1,628 (8.7) 248/2,635 (9.4) 886/8,360 (10.6)
Oxygen saturation, percentage, median (IQR) 98 (96–100) 96 (94–98) 95.5 (90–98) 100 (98–100) 98 (95–99)
Blantyre coma score, median (range) 5 (3–5) 5 (2–5) 5 (2–5) 5 (2–5) 5 (2–5)
Primary diagnosis, n (%)
Malaria (not severe or cerebral) 392/4,992 866/4,206 449/2,610 702/3,537 2,409/15,345
(7.9) (20.6) (17.2) (19.9) (15.7)
Severe or cerebral malaria 1,446/4,992 1,030/4,206 634/2,610 871/3,537 3,981/15,345
(29.0) (24.5) (24.3) (24.6) (25.9)
Pneumonia (not severe) 396/4,992 201/4,206 189/2,610 134/3,537 920/15,345
(7.9) (4.8) (7.2) (3.8) (6.0)
Severe pneumonia 1,279/4,992 566/4,206 384/2,610 771/3,537 3,000/15,345
(25.6) (13.5) (14.7) (21.8) (19.6)
Sepsis or septicemia 557/4,992 551/4,206 418/2,610 272/3,537 1,798/15,345
(11.2) (13.1) (16.0) (7.7) (11.7)
Severe anemia malaria 148/4,992 64/4,206 213/2,610 394/3,537 819/15,345
(3.0) (1.5) (8.2) (11.1) (5.3)
Meningitis 14/4,992 3/4,206 3/2,610 3/3,537 23/15,345
(0.3) (0.1) (0.1) (0.1) (0.1)
Other 760/4,992 925/4,206 320/2,610 390/3,537 2,395/15,345
(15.2) (22.0) (12.3) (11.0) (11.6)
a

MUAC, mid upper arm circumference.

b

Children exposed to HIV-positive mothers.